| Description |
1 online resource (382 p.) |
| Contents |
Intro -- Recent Developments in Applied Microbiology and Biochemistry -- Copyright -- Dedication -- Contents -- Contributors -- Preface and acknowledgments -- Foreword -- Section A: Medical microbiology and biochemistry -- Chapter 1: Recent developments in vaccines strategies against human viral pathogens -- 1. Introduction -- 2. Virus-like particles -- 3. Recombinant proteins and synthetic peptides -- 4. Recombinant bacteria as vaccine vectors -- 5. Nucleic acid vaccines -- 6. Viral vector technology -- 6.1. Adenovirus vectors -- 6.2. Poxvirus vectors |
|
6.3. Adeno-associated virus (AAV) vectors -- 6.4. Other viral vectors -- 7. Future perspectives and conclusion -- References -- Chapter 2: Endophytic microflora: The fountainhead of anticancer metabolites-A systematic review -- 1. Introduction -- 2. Endophytes: Sources of bioactive metabolites -- 3. Endophytes: Sources of anticancer metabolites -- 4. Anticancer metabolites from endophytes of terrestrial plants -- 5. Anticancer metabolites from marine endophytes -- 6. Challenges and future prospects of exploitation of endophytes for pharmaceutical applications -- References |
|
Chapter 3: Next-generation probiotics and obesity-A mini systematic review -- 1. Introduction -- 2. Causes of obesity -- 3. Obesity and its influence on human health -- 4. Probiotics-A gateway to treat obesity -- 5. Probiotics-Their role in gut metabolism -- 6. Next-generation probiotics and its importance -- 6.1. Akkermansia muciniphila -- 6.2. Christensenella minuta -- 6.3. Parabacteroides goldsteinii -- 7. Conclusion and future prospective -- References -- Chapter 4: Role of microbial metabolites in regulating host immunity -- 1. Introduction |
|
2. Methods employed in analyzing the relationship between the host immune system and the microbiota -- 3. Structural composition of the intestinal microbiota -- 4. Microbial metabolites and host immunity -- 5. Short-chain fatty acids -- 6. Tryptophan: AhR ligands -- 7. Retinoic acid -- 8. Vitamins -- 9. Polyamines -- 10. Bile acids -- 11. Neurochemicals -- 12. Detrimental effects of metabolites on the immune system -- 13. Conclusion -- References -- Chapter 5: The hidden risk of health-care-associated hepatitis C virus infection: Scenarios, past, present, and future -- 1. Introduction |
|
2. Global epidemiology of HCV -- 2.1. HCV epidemiology in developed countries -- 2.2. HCV epidemiology in developing countries -- 3. Modes and sources of transmission -- 3.1. Transmission of HCV from infected patients to noninfected patients -- 3.1.1. Mother to baby -- 3.1.2. Injection drug users -- 3.2. Transmission of HCV by infected hemodialysis units -- 3.3. Transmission of HCV by the administration of blood products -- 3.4. Transmission of HCV from infected patients to health-care workers -- 4. Signs and symptoms of HCV infection -- 5. Existing treatment and preventive measures of HCV |
| Notes |
Description based upon print version of record |
| Subject |
Microbiology.
|
|
microbiology.
|
|
Microbiology.
|
| Form |
Electronic book
|
| ISBN |
9780128214077 |
|
0128214074 |
|
